Results 91 to 100 of about 9,625,606 (401)

Microphysiological Glomerular Filtration Barriers: Current Insights, Innovations, and Future Applications

open access: yesAdvanced Biology, EarlyView.
The glomerular filtration barrier (GFB) is the first step of blood filtration by the kidneys. The concerning increase of kidney diseases makes the development of new models essential. In this context, microphysiological glomerular filtration barriers focus on closely reproducing the physiological architecture of the in vivo GFB: podocytes, glomerular ...
Manon Miran   +5 more
wiley   +1 more source

Graves´ disease presenting with complete heart block in a South African lady from Mthatha: a case report

open access: yesPAMJ Clinical Medicine, 2020
Graves´ disease (GD) is an autoimmune thyroid disease first described by Robert Graves in 1835. Patients with GD usually present with symptoms such as heat intolerance, palpitations, tremors, and weight loss.
Khaled Elmezughi   +4 more
doaj   +1 more source

Investigating the Cellular Effects of GALC Dosing in Enzyme Replacement Therapy for Krabbe Disease Supports the Role of Nanomedicine

open access: yesAdvanced Biology, EarlyView.
A detailed workflow for recombinant GALC production and characterization is presented to support enzyme replacement therapy for Krabbe disease. In vitro assays demonstrate that physiological GALC doses restore enzymatic activity and autophagic flux without affecting cell viability, whereas higher doses impair autophagy and reduce viability.
Ambra Del Grosso   +5 more
wiley   +1 more source

Selenium and Graves’ Disease

open access: yesActa Medica Iranica
Selenium, a trace element present in specific selenoproteins, is essential for thyroid hormone metabolism. Selenium is also an antioxidant with immunosuppressive properties and may help in managing thyroid autoimmune diseases, including Graves’ (GD ...
Vahab Fatourechi, Hassan M. Heshmati
doaj   +1 more source

Death by Suicide in Graves' Disease and Graves' Orbitopathy: A Nationwide Danish Register Study.

open access: yesThyroid, 2017
BACKGROUND Graves' disease (GD) is associated with excess morbidity and mortality, but little is known about unnatural manners of death and the potential relation with Graves' orbitopathy (GO).
Charlotte Ferløv-Schwensen   +2 more
semanticscholar   +1 more source

Adipose Mesenchymal Stem Cell‐Derived Exosomes in Conjunction with Roflumilast Ameliorate Chronic Kidney Disease Through the Modulation of Fibrosis and Inflammation

open access: yesAdvanced Biology, EarlyView.
The novelty of this study showed that the injection of exosomes produced from ADMSCs in combination with Roflumilast poses a more favorable therapeutic outcome for CKD induced by Adriamycin, compared to therapy with exosomes or Roflumilast alone. Roflumilast and exosomes treatment lowered the expression of the apoptotic, fibrotic, and inflammatory ...
Mohamed Ali   +5 more
wiley   +1 more source

Association between thymic hyperplasia and serum calcium level in Graves’ disease

open access: yesBMC Endocrine Disorders
Background Graves' disease increases bone resorption in hyperthyroidism, leading to elevated serum calcium levels and a negative bone balance. Thymic hyperplasia is observed in some Graves' disease patients.
Jing Zeng, Lan Li, Dong Wei
doaj   +1 more source

Overweight as a biomarker for concomitant thyroid cancer in patients with Graves’ disease

open access: yesFrontiers in Endocrinology
The incidence of concomitant thyroid cancer in Graves’ disease varies and Graves’ disease can make the diagnosis and management of thyroid nodules more challenging. Since the majority of Graves’ disease patients primarily received non-surgical treatment,
Joonseon Park   +4 more
doaj   +1 more source

Postoperative Outcomes in Graves' Disease Patients: Results from the Nationwide Inpatient Sample Database.

open access: yesThyroid, 2017
BACKGROUND Current surgical indications for Graves' disease include intractability to medical and/or radioablative therapy, compressive symptoms, and worsening ophthalmopathy.
G. Rubio   +5 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy